{"id":"https://openalex.org/W2117062136","doi":"https://doi.org/10.1177/1087054705281121","title":"A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR\u00ae) and Atomoxetine (Strattera\u00ae) in School-Aged Children With Attention Deficit/Hyperactivity Disorder","display_name":"A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR\u00ae) and Atomoxetine (Strattera\u00ae) in School-Aged Children With Attention Deficit/Hyperactivity Disorder","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-01","ids":{"openalex":"https://openalex.org/W2117062136","doi":"https://doi.org/10.1177/1087054705281121","mag":"2117062136","pmid":"https://pubmed.ncbi.nlm.nih.gov/16371674"},"language":"en","primary_location":{"id":"doi:10.1177/1087054705281121","doi":"https://doi.org/10.1177/1087054705281121","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1087054705281121","pdf_url":null,"source":{"id":"https://openalex.org/S4019948","display_name":"Journal of Attention Disorders","issn_l":"1087-0547","issn":["1087-0547","1557-1246"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Attention Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2117062136"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113575577","display_name":"Sharon B. Wigal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sharon B. Wigal","raw_affiliation_strings":["University of California, Irvine,","Child Development Center, University of California, Irvine, CA 92612, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine,","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Child Development Center, University of California, Irvine, CA 92612, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041808631","display_name":"James J. McGough","orcid":"https://orcid.org/0000-0001-8007-9086","observed_orcids":["https://orcid.org/0000-0001-8007-9086"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James J. McGough","raw_affiliation_strings":["University of California, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044457835","display_name":"James T. McCracken","orcid":"https://orcid.org/0000-0003-0370-0777","observed_orcids":["https://orcid.org/0000-0003-0370-0777"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James T. McCracken","raw_affiliation_strings":["University of California, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070269405","display_name":"Joseph Biederman","orcid":"https://orcid.org/0000-0001-8233-663X","observed_orcids":["https://orcid.org/0000-0001-8233-663X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph Biederman","raw_affiliation_strings":["Harvard University and Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard University and Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069963123","display_name":"Thomas J. Spencer","orcid":"https://orcid.org/0000-0001-5661-3293","observed_orcids":["https://orcid.org/0000-0001-5661-3293"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas J. Spencer","raw_affiliation_strings":["Harvard University and Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard University and Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109337851","display_name":"Kelly Posner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kelly L. Posner","raw_affiliation_strings":["Columbia University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036802141","display_name":"Tim L. Wigal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tim L. Wigal","raw_affiliation_strings":["University of California, Irvine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068191739","display_name":"Scott Haden Kollins","orcid":"https://orcid.org/0000-0001-6847-6935","observed_orcids":["https://orcid.org/0000-0001-6847-6935"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott H. Kollins","raw_affiliation_strings":["Duke University Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical School","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013948458","display_name":"Tanya M. Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tanya M. Clark","raw_affiliation_strings":["Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David A. Mays","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David A. Mays","raw_affiliation_strings":["Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110684884","display_name":"Yuxin Zhang","orcid":"https://orcid.org/0000-0003-0794-7646","observed_orcids":["https://orcid.org/0000-0003-0794-7646"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuxin Zhang","raw_affiliation_strings":["Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048537711","display_name":"Simon J. Tulloch","orcid":"https://orcid.org/0000-0002-9000-4835","observed_orcids":["https://orcid.org/0000-0002-9000-4835"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simon J. Tulloch","raw_affiliation_strings":["Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals, Inc., on behalf of the SLI381.404 Study Group","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":null,"fwci":5.4762,"has_fulltext":false,"cited_by_count":130,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96010653,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"275","last_page":"289"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9599999785423279},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.8009999990463257},{"id":"https://openalex.org/keywords/adhd-medication","display_name":"ADHD medication","score":0.6420000195503235},{"id":"https://openalex.org/keywords/school-aged-children","display_name":"school-aged children","score":0.6899999976158142},{"id":"https://openalex.org/keywords/deportment","display_name":"deportment","score":0.8090000152587891},{"id":"https://openalex.org/keywords/adhd-combined-type","display_name":"combined type ADHD","score":0.421999990940094},{"id":"https://openalex.org/keywords/laboratory-schools","display_name":"experimental schools","score":0.40299999713897705},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.9371330738067627},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.7925581932067871},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.6955022811889648},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6655920743942261},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.5938498973846436},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.49348413944244385},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4752854108810425},{"id":"https://openalex.org/C3020385749","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Extended release","level":2,"score":0.4745786190032959},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.46257948875427246},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4511604905128479},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.44893181324005127},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38958579301834106},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2632724642753601},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.23364901542663574},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.1733226478099823},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16354456543922424},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1219085156917572},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000662","descriptor_name":"Amphetamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/1087054705281121","doi":"https://doi.org/10.1177/1087054705281121","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1087054705281121","pdf_url":null,"source":{"id":"https://openalex.org/S4019948","display_name":"Journal of Attention Disorders","issn_l":"1087-0547","issn":["1087-0547","1557-1246"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Attention Disorders","raw_type":"journal-article"},{"id":"pmid:16371674","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16371674","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of attention disorders","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.876.6039","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.876.6039","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jad.sagepub.com/content/9/1/275.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G7275401088","display_name":"Evaluation of Stimulant Drugs","funder_award_id":"K23MH002042","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W34434431","https://openalex.org/W92757306","https://openalex.org/W166008495","https://openalex.org/W253326700","https://openalex.org/W273282633","https://openalex.org/W367527110","https://openalex.org/W1608415289","https://openalex.org/W1963735974","https://openalex.org/W1967979227","https://openalex.org/W1968161022","https://openalex.org/W1968752176","https://openalex.org/W1984207232","https://openalex.org/W1985603217","https://openalex.org/W1999403328","https://openalex.org/W2016483680","https://openalex.org/W2016995778","https://openalex.org/W2025120697","https://openalex.org/W2029569572","https://openalex.org/W2048481057","https://openalex.org/W2052824975","https://openalex.org/W2057209503","https://openalex.org/W2062714266","https://openalex.org/W2063286745","https://openalex.org/W2066201328","https://openalex.org/W2093528493","https://openalex.org/W2113181557","https://openalex.org/W2122518346","https://openalex.org/W2123980944","https://openalex.org/W2137881115","https://openalex.org/W2159011576","https://openalex.org/W2166577179","https://openalex.org/W2285134444","https://openalex.org/W2323149989","https://openalex.org/W2599734864","https://openalex.org/W3090293687","https://openalex.org/W3196369884","https://openalex.org/W3215125900","https://openalex.org/W4250858368"],"related_works":["https://openalex.org/W2045053874","https://openalex.org/W2018912237","https://openalex.org/W1994132210","https://openalex.org/W2059930343","https://openalex.org/W2052372131","https://openalex.org/W1999197123","https://openalex.org/W2013550669","https://openalex.org/W2058463020"],"abstract_inverted_index":{"Mixed":[0],"amphetamine":[1],"salts":[2],"extended":[3,102],"release":[4],"(MAS":[5],"XR;":[6],"Adderall":[7],"XR)":[8],"and":[9,50,80,86,107],"atomoxetine":[10,74,121],"(Strattera)":[11],"were":[12,63,95],"compared":[13],"in":[14,30,56,122],"children":[15,123],"6":[16],"to":[17],"12":[18],"years":[19],"old":[20],"with":[21,124],"attention":[22],"deficit/hyperactivity":[23],"disorder":[24],"(ADHD)":[25],"combined":[26],"or":[27],"hyperactive/impulsive":[28],"type":[29],"a":[31],"randomized,":[32],"double-blind,":[33],"multicenter,":[34],"parallel-group,":[35],"forced-dose-escalation":[36],"laboratory":[37],"school":[38],"study.":[39],"Primary":[40],"efficacy":[41,110],"measure":[42],"was":[43],"the":[44],"SKAMP":[45,58],"(Swanson,":[46],"Kotkin,":[47],"Agler,":[48],"M-Flynn,":[49],"Pelham)":[51],"behavioral":[52],"rating":[53],"scale.":[54],"Changes":[55],"mean":[57],"deportment":[59],"scores":[60],"from":[61],"baseline":[62],"significantly":[64],"greater":[65,108],"for":[66,73,97],"MAS":[67,112],"XR":[68,113],"(n":[69,75],"=":[70,76],"102)":[71],"than":[72,120],"101)":[77],"overall":[78],"(-0.56":[79],"-0.13,":[81],"respectively;":[82],"p":[83],"<":[84,91],".0001)":[85],"at":[87],"each":[88],"week":[89],"(p":[90],".001).":[92],"Adverse":[93],"events":[94],"similar":[96],"both":[98],"treatment":[99],"groups.":[100],"The":[101],"time":[103],"course":[104],"of":[105,111],"action":[106],"therapeutic":[109],"suggests":[114],"that":[115],"it":[116],"is":[117],"more":[118],"effective":[119],"ADHD.":[125]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2117062136","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
